HOXB8 and osteosarcoma: The CRC calling algorithms[19, 20] of osteosarcoma predicted HOXB8 as a top candidate of CRC master TF with the highest IN and OUT degree index in chemoresistant and metastatic osteosarcoma (Figure 1b; Figure S1f, Supporting Information).